Kilitch Drugs (India) Limited (NSE: KILITCH), ISIN INE729D01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
KILITCH last traded at ₹189.00 (+2.80%), with a 52-week range of ₹121.10 to ₹226.50 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 63.77%, FIIs 0.12%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 84/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.